BioAdaptives Signs Non-Exclusive License With LY Research to Market Patented Bioavailable Resveratrol for Both Animals and Humans
April 18, 2023 08:00 ET
|
BioAdaptives, Inc.
LAS VEGAS, NV, April 18, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – BioAdaptives, Inc. (OTCMkts: BDPT) announced today the signing of a non-exclusive license agreement with LY Research Corporation...
BioAdaptives Inc. (OTC BDPT) Announces New Appointment to the Board of Directors - Visionary Futurist , Wellness Pioneer and Marketer, David Allen, PhD
April 13, 2023 08:00 ET
|
BioAdaptives, Inc.
LAS VEGAS, NV, April 13, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – BioAdaptives, Inc. (OTCMkts: BDPT) announced today the appointment of David Allen, PhD to its Board of Directors. Edward Jacobs,...
BioAdaptives Inc. Announced Today the Signing of a License for Eye Health due to Myopia and Presbyopia; a Patent Valued at US$ 570,000,000
March 30, 2023 08:00 ET
|
BioAdaptives, Inc.
LAS VEGAS, NV, March 30, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – BioAdaptives, Inc. (OTCMkts: BDPT) announced today the signing of a second non-exclusive license agreement with LY Research...
BioAdaptives Signs Non-Exclusive License With LY Research to Market Patented Product for Glucose Management
March 28, 2023 08:00 ET
|
BioAdaptives, Inc.
LY Research Patent # US 8,114,444 B2 is Valued at US$210,000,000 LAS VEGAS, NV, March 28, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – BioAdaptives, Inc. (OTCMkts: BDPT) announced today the...